Sponsor:
Hoffmann-La Roche
Code:
NCT05630066
Conditions
Angelman Syndrome
Eligibility Criteria
Sex: All
Age: 5 - 17
Healthy Volunteers: Not accepted
Interventions
60 mg QD Alogabat
40 mg QD Alogabat
7 mg QD Alogabat
Part 2 Adult Alogabat High Dose (aged 15-17)
Alogabat
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations